Creating shareholder value through M&A in the life sciences sector

Creating shareholder value through M&A in the life sciences sector

Gregory K. Bell
Life Sciences

In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.

Download PDF